PEU-17692-38034
4 vaccinations
1 coded response
35 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 916 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XB7-40677-33226
Child or adolescent in my care · Male · 2022-07-30
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-10-15
Dose 3 — Pfizer-BioNTech
- 2022-01-09
-
2022-10-15
Survey response — 12 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Dose 4 — Pfizer-BioNTech
-
2022-11-05
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2022-12-16
- 2023-02-03
- 2023-05-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-11-04 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: Upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release